Jonathan R. Young MD, Presenter: Nothing to Disclose

Jocelyn A. Young, Abstract Co-Author: Nothing to Disclose

Daniel Jason Aaron Margolis MD, Abstract Co-Author: Research Grant, Siemens AG

Jiaoti Huang, Abstract Co-Author: Nothing to Disclose

Steven Satish Raman MD, Abstract Co-Author: Consultant, Bayer AG Consultant, Covidien AG

1. Quantitative imaging features, namely the magnitude of enhancement on multiphasic MDCT, can assist in discriminating the most common subtypes of renal cell carcinoma (clear cell, papillary, and chromophobe) and oncocytoma, a benign mimic of RCC. 2. Qualitative imaging features, such as pattern of enhancement, neovascularity, calcification, and contour, can also assist in discriminating clear cell RCC, papillary RCC, chromophobe RCC, and oncocytoma. 3. Because clear cell RCC, papillary RCC, chromophobe RCC, and oncocytoma have differing prognoses, a non-invasive means of discriminating between these entities can be of great clinical value and can thus guide further management.  

1. Epidemiology of clear cell RCC, papillary RCC, chromophobe RCC, and oncocytoma 2. Prognoses of clear cell RCC, papillary RCC, chromophobe RCC, and oncocytoma 3. Multiphasic enhancement of clear cell RCC, papillary RCC, chromophobe RCC, and oncocytoma 4. Qualitative imaging features, including pattern of enhancement, neovascularity, calcification, and contour, of clear cell RCC, papillary RCC, chromophobe RCC, and oncocytoma 5. Histopathologic features of clear cell RCC, papillary RCC, chromophobe RCC, and oncocytoma  

http://abstract.rsna.org/uploads/2014/14017803/14017803_ewkc.pdf

Young, J, Young, J, Margolis, D, Huang, J, Raman, S, Separating the Subtypes: A Radiologic and Histopathologic Review of the Most Common Subtypes of Renal Cell Carcinoma (RCC) and Oncocytoma, a Benign Mimic of RCC.  Radiological Society of North America 2014 Scientific Assembly and Annual Meeting, - ,Chicago IL. http://archive.rsna.org/2014/14017803.html